Vipragen offers an extensive array of Genotoxicity studies in India, encompassing both in vitro and in vivo assessments to identify potential carcinogenic or mutagenic compounds capable of causing genetic alterations in somatic or germ cells. These studies also evaluate the potential for DNA damage, which can lead to chromosomal structural changes and disruptions in the mitotic apparatus, resulting in variations in chromosome number.
Vipragen's Genotoxicity services include well-established tests and their respective methodologies and deliverables such as: